Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

Phospholipase A2 inhibitor

DRUG CLASS:

Phospholipase A2 inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

hydroxychloroquine (7)

hydroxychloroquine MDT (0)

icosapent ethyl (0)

hydroxychloroquine (7)

hydroxychloroquine MDT (0)

icosapent ethyl (0)

›

SMAD4 deletion	Pancreatic Adenocarcinoma	SMAD4 deletion	Pancreatic Adenocarcinoma	gemcitabine + albumin-bound paclitaxel + hydroxychloroquine Sensitive: C3 – Early Trials gemcitabine + albumin-bound paclitaxel + hydroxychloroquine Sensitive : C3	gemcitabine + albumin-bound paclitaxel + hydroxychloroquine Sensitive: C3 – Early Trials gemcitabine + albumin-bound paclitaxel + hydroxychloroquine Sensitive : C3
KRAS G12D + STK11 mutation	Lung Cancer	KRAS G12D + STK11 mutation	Lung Cancer	hydroxychloroquine Sensitive: D – Preclinical hydroxychloroquine Sensitive : D	hydroxychloroquine Sensitive: D – Preclinical hydroxychloroquine Sensitive : D
GNAQ Q209L	Uveal Melanoma	GNAQ Q209L	Uveal Melanoma	trametinib + hydroxychloroquine Sensitive: D – Preclinical trametinib + hydroxychloroquine Sensitive : D	trametinib + hydroxychloroquine Sensitive: D – Preclinical trametinib + hydroxychloroquine Sensitive : D
GNA11 Q209L	Uveal Melanoma	GNA11 Q209L	Uveal Melanoma	trametinib + hydroxychloroquine Sensitive: D – Preclinical trametinib + hydroxychloroquine Sensitive : D	trametinib + hydroxychloroquine Sensitive: D – Preclinical trametinib + hydroxychloroquine Sensitive : D
GNAQ Q209P	Uveal Melanoma	GNAQ Q209P	Uveal Melanoma	trametinib + hydroxychloroquine Sensitive: D – Preclinical trametinib + hydroxychloroquine Sensitive : D	trametinib + hydroxychloroquine Sensitive: D – Preclinical trametinib + hydroxychloroquine Sensitive : D
Chr del(17p)	Chronic Lymphocytic Leukemia	Chr del(17p)	Chronic Lymphocytic Leukemia	hydroxychloroquine Sensitive: D – Preclinical hydroxychloroquine Sensitive : D	hydroxychloroquine Sensitive: D – Preclinical hydroxychloroquine Sensitive : D
Chr del(11q)	Chronic Lymphocytic Leukemia	Chr del(11q)	Chronic Lymphocytic Leukemia	hydroxychloroquine Sensitive: D – Preclinical hydroxychloroquine Sensitive : D	hydroxychloroquine Sensitive: D – Preclinical hydroxychloroquine Sensitive : D
PDE3A overexpression	Acute Myelogenous Leukemia	PDE3A overexpression	Acute Myelogenous Leukemia	idarubicin hydrochloride + anagrelide Sensitive: D – Preclinical idarubicin hydrochloride + anagrelide Sensitive : D	idarubicin hydrochloride + anagrelide Sensitive: D – Preclinical idarubicin hydrochloride + anagrelide Sensitive : D